2023 PD Therapeutics Conference

*At this time, there are no current CDC guideline or local rules and regulations in place for COVID-19. As such, this meeting will not require proof of vaccination or testing, and while masking is encouraged, it will be optional. As the course of the pandemic shifts or local, state or federal regulations change, we will follow science and update all attendees. For international attendees, please make sure to check the rules on arrival and departure with your country and the United States. The Parkinson's Disease Therapeutics Conference is The Michael J. Fox Foundation's annual scientific conference and the only one in the world focused exclusively on Parkinson's disease drug development. The 15th Annual PD Therapeutics Conference is scheduled to be held on October 19, 2023, in New York.

Each year, the PD Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through speaker presentations and a poster session. The event is a platform for field leaders to share new and unpublished results and for fostering new relationships and collaborations.

Thank you for your tremendous enthusiasm for this year's event. Registration has reached its maximum capacity. We will shortly inform those who had joined the waitlist about their potential to attend.

For any questions, please contact researchmeetings@michaeljfox.org.

Jamie Adams, MD | University of Rochester 

Tien Dam, MD | Biogen

Vicky DiBiaso, PhD | Sanofi 

Jamie Eberling, PhD | The Michael J. Fox Foundation 

Tanya Fischer, MD, PhD | Biohaven

Alison Handler, PharmD, RPh | Novartis 

Karl Kieburtz, MD, MPH | University of Rochester 

Catherine Kopil, PhD | The Michael J. Fox Foundation 

Ken Marek, MD | Institute for Neurodegenerative Disorders 

Soania Mathur, MD | MJFF Patient Council Member 

Kalpana Merchant, PhD | TransThera Consulting 

Tom Montine, MD, PhD | Stanford University 

Karoly Nikolich, PhD | Alkahest Inc.

Gennaro Pagano, MD, PhD | Roche 

Niels Plath, PhD | Muna Therapeutics 

Kathleen Poston, MD, MS | Stanford University 

Gary Rafaloff | MJFF Patient Council Member 

Andrew Singleton, PhD | National Institutes of Health

David Stone, PhD | Cerevel Therapeutics

Bill Shrader, PhD | AcureX 

Paul Thompson, PhD | Mission Therapeutics 

Kendall Van Keuren-Jensen, PhD | Translational Genomics Research Institute 

The 15th annual Parkinson's Disease Therapeutics Conference is made possible by the support of our generous sponsors: 

Interested in Sponsorship Opportunities?

View our sponsorship opportunities menu to support this year's conference.

Contact our Research Alliances team at researchpartnerships@michaeljfox.org with questions. 

Address

Quorum by Convene 
1221 Avenue of Americas
New York, NY 10020